Systemic complications of the bidirectional intraoperative chemotherapy with intravenous ifosfamide and hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin

BACKGROUND: Ifosfamide has recently used as the intravenous component of bidirectional intraoperative chemotherapy (BDIC) with hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin. Little is known about the systemic toxicities of this BDIC regimen. Therefore, this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakeam, Hakeam, Ayman, Azzam, Waleed, Al Taweel, Amen, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881663/
https://www.ncbi.nlm.nih.gov/pubmed/31799375
http://dx.doi.org/10.1515/pp-2019-0025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881663/
https://www.ncbi.nlm.nih.gov/pubmed/31799375
http://dx.doi.org/10.1515/pp-2019-0025

Ejemplares similares